Molecular Insights on the Peripheral and Intratumoral Effects of Systemic High-Dose rIL-2 (Aldesleukin) Administration for the Treatment of Metastatic Melanoma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-11-1650
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Dose Efficacy Study of Two Schedules of High-Dose Bolus Administration of Interleukin 2 and Interferon Alpha in Metastatic Melanoma

British Journal of Cancer
Cancer ResearchOncology
1996English

Intratumoral Delivery of Tavokinogene Telseplasmid Yields Systemic Immune Responses in Metastatic Melanoma Patients

Annals of Oncology
MedicineOncologyHematology
2020English

The Effects of High and Low Dose Nicotine Administration on Neurogenesis

Biomedical Journal of Scientific & Technical Research
2019English

Pilot Clinical Trials Testing the Safety and Effects on the Metastatic Melanoma Microenvironment of Intratumoral Interferon-Gamma or Imiquimod, Plus a Multipeptide Melanoma Vaccine

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Method of Local Administration of rIL-2 and Its Efficacy.

Japanese jornal of Head and Neck Cancer
1990English

Hepatic Resection for Metastatic Melanoma: The Role of Surgical Treatment

HPB
HepatologyGastroenterology
2016English

Oral High-Dose Ankaferd Administration Effects on Gastrointestinal System

International Journal of Medical Sciences
Medicine
2013English

Emerging Insights Into the Molecular Pathogenesis of Uveal Melanoma

Future Oncology
MedicineCancer ResearchOncology
2008English

An Exploratory Study of Systemic Administration of the Toll-Like Receptor-7 Agonist 852A in Patients With Refractory Metastatic Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy